MARC details
| 000 -LEADER |
|---|
| fixed length control field |
nam a22 7a 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20200921161008.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
200921b xxu||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780853697145 |
| 082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Edition number |
23 |
| Classification number |
615.507 24 |
| Item number |
DHI |
| 100 ## - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Durham, Todd A. |
| 110 ## - MAIN ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
Turner, J. Rick. |
| 245 ## - TITLE STATEMENT |
|---|
| Title |
Introduction to statistics in pharmaceutical clinical trials / |
| Statement of responsibility, etc. |
by Todd A. Durham, J. Rick Turner. |
| Medium |
Eng. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc. |
London ; Chicago : |
| Name of publisher, distributor, etc. |
Pharmaceutical Press, |
| Date of publication, distribution, etc. |
2008. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Other physical details |
xii, 226 p.: |
| Dimensions |
22 cm. |
| 505 ## - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Section 1 Setting the Scene; Statistic, Statistics and Statistical Analyses; New Drug Development; Section 2 Design, Analysis and Interpretation; Data, Central Tendency and Variation; Research Questions and Research Hypotheses; Study Design and Methodology; Hypothesis Testing and Estimation; Section 3 Pre-clinical Drug Development; Overview of Pre-clinical Drug Development; Pharmacokinetic Studies; Pharmacodynamic Studies; Section 4 Clinical Drug Development; Phase 1: Clinical Trials; Confirmatory Clinical Trials: Safety Data; Confirmatory Clinical Trials: Efficacy Data; Health Outcomes Data; Section 5 Additional Pharmaceutical Statistical Techniques; Analysis of Frequencies; Analysis of Association and Prediction; Analysis of Ranked Outcomes; Section 6 Writing Regulatory Documents and Scientific Manuscripts; Scientific Communication: Goals and Necessary Statistical Skills. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
A self-contained introduction to Statistics, presented in the context of clinical trials and pharmaceutical drug development. This title focuses on the statistical analyses most commonly used in drug development. It emphasises the importance of descriptive statistics as well as inferential statistics. |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Clinical trials --Statistical methods. |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Drug development--Statistical methods. |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Études cliniques --Méthodes statistiques. |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Médicaments -- Développement -- Méthodes statistiques. |
| 655 ## - INDEX TERM--GENRE/FORM |
|---|
| Source of term |
Electronic books |
| Genre/form data or focus term |
Livres numériques |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Dewey Decimal Classification |
| Koha item type |
Book |